This is a buying oppt (IMO). The Q earning has nothing to do with this stcok performance. We know Calypte is in deep debt and loss money Q after Q. But there is a big catch...Aware HIV 1/2 OMT is real...is being approved by China FDA...
Read this article...
Calypte AWARE HIV-1/2 OMT antibody test using oral fluid: special challenges of rapid HIV testing in the developing world.
2006 Mar;6(2):139-44.
Gottfried TD, Mink RW, Phanuphak P.
Technology Consultant, Orinda, CA 94563, USA.
The testing and counseling of persons at risk for infection with HIV and their subsequent treatment remains the primary tool to curb worldwide transmission of the virus. Rapid HIV tests address the need in the developing world for accurate, easy-to-use tests that do not require laboratory equipment or highly trained professionals for implementation or refrigeration for storage. Calypte Biomedical has recently developed the Calypte AWARE HIV-1/2 OMT antibody test using oral fluid samples. This test has demonstrated high sensitivity and specificity for specimens collected in target areas where increased testing is needed. The inexpensive dipstick format in combination with the use of an alternative fluid to blood provides an improved testing procedure for areas with limited resources.
Peace!
C-Starz
